Portfolio company
Aureka Biotechnologies
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops artificial intelligence platforms and antibody therapeutics for pharmaceutical and biotechnology organisations to accelerate the discovery and design of medicines.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Tessel Biosciences
The company develops artificial intelligence models and patient-derived virtual tissues to accelerate drug discovery for pharmaceutical and biotechnology organisations.
Auron Therapeutics
This company develops small-molecule drugs using an AI-powered platform to treat patients with cancer and inflammatory diseases.
Metaphore Biotechnologies
This biotechnology company develops an artificial intelligence platform to design functional antibody medicines for pharmaceutical partners and patients with autoimmune, metabolic or oncology conditions.
Xaira
The company develops artificial intelligence platforms to design and develop antibody-based medicines for patients with various diseases.
Antiverse
This company uses generative AI to design functional antibody biologics for pharmaceutical organisations targeting complex medical conditions and transmembrane proteins.
Nabla Bio
This company develops generative artificial intelligence and high-throughput screening platforms to design therapeutic antibodies for pharmaceutical and biotechnology partners.
Aqemia
This company develops a drug discovery platform using physics-based algorithms and artificial intelligence for pharmaceutical and biotechnology organisations.
Generate Biomedicine
This company develops protein-based therapeutics using a generative artificial intelligence platform for pharmaceutical partners and biotechnology firms.
